The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Randomized Phase II study of Reolysin in Patients with Previously Treated Advanced or Metatstatic Non Small Cell Lung Cancer (NSCLC) receiving Standard Salvage Chemotherapy – Canadian Cancer Trials Group IND 211.
 
Donald Morris
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Novartis Canada Pharmaceuticals Inc; Pfizer
 
Dongsheng Tu
No Relationships to Disclose
 
Mustapha Ali Tehfe
Consulting or Advisory Role - Amgen; Celgene; Lilly
 
Garth Andrew Nicholas
Research Funding - Novocure
 
John R. Goffin
Consulting or Advisory Role - Amgen; Boehringer Ingelheim
 
Richard William Gregg
No Relationships to Disclose
 
Frances A. Shepherd
Stock and Other Ownership Interests - AstraZeneca; Lilly
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Merck/Schering Plough; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Recombio; Synta
Research Funding - Boehringer Ingelheim (Inst)
 
Nevin Murray
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
 
Rafal Wierzbicki
No Relationships to Disclose
 
Christopher W. Lee
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Pfizer; Roche
 
Sara Kuruvilla
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb
Research Funding - AstraZeneca; Bayer
 
Bruce Keith
No Relationships to Disclose
 
A Ahmed
No Relationships to Disclose
 
Normand Blais
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Merck
 
Glenwood D. Goss
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Pfizer
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer
 
Grzegorz Korpanty
No Relationships to Disclose
 
Joana Sederias
No Relationships to Disclose
 
Scott Andrew Laurie
No Relationships to Disclose
 
Lesley Seymour
Stock and Other Ownership Interests - AstraZeneca
Honoraria - Innate Pharma
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Innate Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Penelope Ann Bradbury
Research Funding - CCTS